Welcome to Xi’an Good Doctor Medical Science and Technology Co., Ltd.website !
Tel: +86 29 82681864
+86 15002902555
Internet Drug Information Service Qualification Certificate: (Shaanxi)-Non-Operating -2023-0143
Home
About
Company Profile
Enterprise culture
Intellectual Property
National Patent & Trademark
Global Patent & Trademark
Academics
Publications
Clinical Trial Sites
Clinical Application - Internal Medicine
Clinical Application - Surgery
Preclinical Studies
Products
Main Equipment
Consumable Accessories
Blog
Corporate News
Industry News
Hyperthermic Perfusion Podcast
Notice & Announcement
Investment Opportunity
Business Partnerships
After-sales Services
Become a Distributor
Contact
Contact Us
Job Opportunities
Expert Advisory Services
中
——
2026.06.28
Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (4) “Clinical Application of Early Postoperative Intraperitoneal Hyperthermic Perfusion Chemotherapy for Gastric Cancer”
Hyperthermic perfusion therapy equipment: TRL-type thermochemotherapy perfusion machine (produced by Harbin Aerospace Science and Technology Development Co., Ltd., the predecessor of Xi’an Good Doctor Medical Science and Technology Co., Ltd.).
2026.06.27
Reposted: Ascites resolution rate exceeds 93%! For advanced tumor‑related effusions, the Circulatory Hyperthermic Perfusion Therapy at Peace Hospital has alleviated suffering in 90% of patients.
Malignant tumors complicated by pleural and peritoneal effusions are a challenging clinical problem.
Good Doctor·Hyperthermic Perfusion | Literature Review and Analysis | (3) “A Controlled Study of Intracavitary Constant-Temperature Circulating Hyperthermic Perfusion Chemotherapy for Malignant Pleural Effusion”
Case selection: The observation group comprised 25 patients aged 39–65 years, including 18 cases of lung cancer, 5 cases of pleural mesothelioma, and 2 cases of breast cancer; 15 were male and 10 were female.
2026.06.25
Reposted: A chronic illness flares up—new opportunities in diagnosis and treatment emerge! Hyperthermic Intraperitoneal Chemotherapy offers a fresh path to hope for patients with advanced peritoneal tumors.
Malignant thoracic and abdominal tumors accompanied by peritoneal implantation, refractory ascites, and postoperative recurrence have long posed significant clinical challenges.
2026.06.24
Reposted: Breakthrough Advances in Intraperitoneal Hyperthermic Perfusion for Gastrointestinal Surgery—Ultrasound-Guided Puncture and Catheter Placement Enables Precision Treatment of Chemotherapy-Resistant Peritoneal Mesothelioma
Peking University Hospital Taiyuan Hospital (Taiyuan Central Hospital), as a designated national regional medical center, has consistently spearheaded innovations in oncology diagnosis and treatment.
2026.06.18
Reprinted: Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Malignant Pleural Effusion Associated with Ovarian Cancer (2026 Edition)
Malignant pleural effusion (MPE) refers to pleural fluid accumulation resulting from primary malignant tumors of the pleura or from metastases of malignancies originating elsewhere that spread to the pleura.
Reprinted: Chinese Expert Consensus on the Diagnosis and Treatment of Female Peritoneal Mesothelioma (2026 Edition)
Peritoneal malignant mesothelioma (PMM) is a highly aggressive malignancy originating from peritoneal mesothelial cells. It is often misdiagnosed as a gynecologic malignancy in female patients, and the overall prognosis after diagnosis remains poor.
Reposted: 2026 Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Gastric Cancer, 2026
Developing diagnostic and treatment guidelines for common malignancies in China—grounded in evidence-based medicine, mindful of the accessibility of clinical products, and incorporating the latest advances in precision medicine—is one of the core missions of the Chinese Society of Clinical Oncology (CSOO). In recent years, a new trend has emerged in the development of clinical practice guidelines: prioritizing the availability of healthcare resources, a approach particularly well-suited to developing countries and to nations and regions characterized by pronounced regional disparities.